Spirepoint Private Client’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,840	Closed	-$1.02M	–	232
2024 Q4	$1.02M	Buy	11,840 +1,129	+11%	+$97.4K	0.13%	98
2024 Q3	$1.02M	Sell	10,711 -769	-7%	-$73.1K	0.13%	97
2024 Q2	$1.05M	Buy	11,480 +514	+5%	+$47K	0.15%	93
2024 Q1	$995K	Buy	+10,966	New	+$995K	0.15%	93